Indications and uses
• temporarily relieves itching and redness caused by pollen, ragweed, grass, animal hair and dander.
• temporarily relieves itching and redness caused by pollen, ragweed, grass, animal hair and dander.
• Adults and children 6 years of age and older: Instill 1 or 2 drops in the affected eye(s) up to 4 times daily. • Children under 6 years: ask a doctor
Naphazoline HCl (0.02675%)
Pheniramine maleate (0.315%)
Redness reliever
Antihistamine
If swallowed, get medical help or contact a Poison Control Center right away. Accidental oral ingestion in infants and children may lead to coma and marked reduction in body temperature.
benzalkonium chloride, boric acid, edetate disodium, hypromellose, purified water, sodium borate, sodium chloride. Hydrochloric acid may be used to adjust pH.
Call: 1-866-767-8975
9383900
LR55211
DISTRIBUTED BY:
RITE AID, 30 HUNTER LANE
CAMP HILL, PA 17011
MADE IN USA
© RITE AID
ITEM 386560
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| NAPHAZOLINE HYDROCHLORIDE | ACTIVE INGREDIENT | MZ1131787D | 3 | |
| PHENIRAMINE MALEATE | ACTIVE INGREDIENT | NYW905655B | 3 | |
| NAPHAZOLINE | ACTIVE MOIETY | H231GF11BV | 3 | |
| PHENIRAMINE | ACTIVE MOIETY | 134FM9ZZ6M | 3 | |
| BENZALKONIUM CHLORIDE | INACTIVE INGREDIENT | F5UM2KM3W7 | 3 | |
| BORIC ACID | INACTIVE INGREDIENT | R57ZHV85D4 | 3 | |
| EDETATE DISODIUM | INACTIVE INGREDIENT | 7FLD91C86K | 3 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | 3 | |
| HYPROMELLOSES | INACTIVE INGREDIENT | 3NXW29V3WO | 3 | |
| SODIUM BORATE | INACTIVE INGREDIENT | 91MBZ8H3QO | 3 | |
| SODIUM CHLORIDE | INACTIVE INGREDIENT | 451W47IQ8X | 3 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 3 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 11822-3865 | 11822-3865-6 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| NAPHAZOLINE HYDROCHLORIDE | MZ1131787D | ACTIB |
| PHENIRAMINE MALEATE | NYW905655B | ACTIB |
| BENZALKONIUM CHLORIDE | F5UM2KM3W7 | IACT |
| BORIC ACID | R57ZHV85D4 | IACT |
| EDETATE DISODIUM | 7FLD91C86K | IACT |
| WATER | 059QF0KO0R | IACT |
| SODIUM BORATE | 91MBZ8H3QO | IACT |
| SODIUM CHLORIDE | 451W47IQ8X | IACT |
| HYDROCHLORIC ACID | QTT17582CB | IACT |
| HYPROMELLOSE, UNSPECIFIED | 3NXW29V3WO | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| HYDROCHLORIC ACID | HYDROCHLORIC ACID | QTT17582CB | AEROSOL, METERED / RESPIRATORY (INHALATION) | 0.7 %w/w | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | TABLET, DELAYED RELEASE / ORAL | 97 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SOLUTION / SUBCUTANEOUS | 1486 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | LIQUID / ORAL | 0.5 mg/1ml | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | SUSPENSION/ DROPS / ORAL | 4 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | TABLET, COATED / ORAL | 54.7 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | INJECTION, SUSPENSION / INTRAMUSCULAR | 1 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SOLUTION / AURICULAR (OTIC) | 18 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SUSPENSION / ORAL | 1126 mg | ||
| BENZALKONIUM CHLORIDE | BENZALKONIUM CHLORIDE | F5UM2KM3W7 | SUSPENSION/ DROPS / OPHTHALMIC | 0.02 %w/v | ||
| HYDROCHLORIC ACID | HYDROCHLORIC ACID | QTT17582CB | SOLUTION / EXTRACORPOREAL | ADJ PH | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SUSPENSION / TOPICAL | 0.32 %w/v | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SUSPENSION / INTRAMUSCULAR | 9 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SHAMPOO / TOPICAL | 150 mg | ||
| HYDROCHLORIC ACID | HYDROCHLORIC ACID | QTT17582CB | INJECTION, POWDER, FOR SOLUTION / INTRATHECAL | ADJ PH | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | SOLUTION/ DROPS / OPHTHALMIC | 0.13 %w/v | ||
| HYDROCHLORIC ACID | HYDROCHLORIC ACID | QTT17582CB | INJECTION / INTRABURSAL | ADJ PH | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | SYSTEM / TOPICAL | 126 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | POWDER, FOR SOLUTION / OPHTHALMIC | 0.9 %w/w | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | CREAM / TOPICAL | 14 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | INJECTION / INTRALESIONAL | 0.05 %w/v | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SYRUP / ORAL | 40 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | SYSTEM / IONTOPHORESIS | 0.1 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / INTRASYNOVIAL | 0.9 %w/v | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | POWDER, FOR SUSPENSION / ORAL | 285 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SUSPENSION/ DROPS / TOPICAL | 0.23 %w/v | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SUSPENSION / INTRA-ARTICULAR | 26 mg | ||
| HYDROCHLORIC ACID | HYDROCHLORIC ACID | QTT17582CB | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRACAVERNOUS | ADJ PH | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SUSPENSION / INTRAVITREAL | 6 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | TABLET, ORALLY DISINTEGRATING / ORAL | 10 mg | ||
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | GRANULE / ORAL | 45 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, EMULSION / INTRAVENOUS | 0.62 %w/v | ||
| BORIC ACID | BORIC ACID | R57ZHV85D4 | EMULSION / OPHTHALMIC | 0.3 %w/v | ||
| HYDROCHLORIC ACID | HYDROCHLORIC ACID | QTT17582CB | GEL, METERED / TOPICAL | ADJ PH | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | INJECTION / INTRAVENOUS | 10 %w/v | ||
| HYDROCHLORIC ACID | HYDROCHLORIC ACID | QTT17582CB | SOLUTION / OPHTHALMIC | 0.31 %w/v | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | SUSPENSION / OPHTHALMIC | 0.06 %w/v | ||
| BENZALKONIUM CHLORIDE | BENZALKONIUM CHLORIDE | F5UM2KM3W7 | SUSPENSION/ DROPS / AURICULAR (OTIC) | 0.02 %w/v | ||
| HYDROCHLORIC ACID | HYDROCHLORIC ACID | QTT17582CB | INJECTION / INTRAVITREAL | ADJ PH | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | TABLET, FILM COATED / ORAL | 4 mg | ||
| BENZALKONIUM CHLORIDE | BENZALKONIUM CHLORIDE | F5UM2KM3W7 | SUSPENSION/ DROPS / TOPICAL | NA | ||
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | CREAM / TOPICAL | 0.1 %w/w | ||
| HYDROCHLORIC ACID | HYDROCHLORIC ACID | QTT17582CB | INJECTION, POWDER, FOR SOLUTION / INTRA-ARTERIAL | ADJ PH | ||
| HYDROCHLORIC ACID | HYDROCHLORIC ACID | QTT17582CB | INJECTION, EMULSION / INTRAMUSCULAR | ADJ PH | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | SOLUTION / RESPIRATORY (INHALATION) | 43 mg | ||
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | SUSPENSION/ DROPS / OPHTHALMIC | 3 mg | ||
| BORIC ACID | BORIC ACID | R57ZHV85D4 | SHAMPOO / TOPICAL | 2 %w/w | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | INJECTION / SOFT TISSUE | 0.05 %w/v | ||
| HYDROCHLORIC ACID | HYDROCHLORIC ACID | QTT17582CB | SOLUTION / NASAL | 91.7 mg/100ml | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | GEL / TOPICAL | 24 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, POWDER, FOR SUSPENSION / SUBCUTANEOUS | NA | ||
| HYDROCHLORIC ACID | HYDROCHLORIC ACID | QTT17582CB | SOLUTION / INTRAOCULAR | ADJ PH | ||
| BORIC ACID | BORIC ACID | R57ZHV85D4 | DROPS / OPHTHALMIC | 1 %w/w | ||
| HYDROCHLORIC ACID | HYDROCHLORIC ACID | QTT17582CB | SYRUP / ORAL | 2.03 mg/1ml | ||
| BENZALKONIUM CHLORIDE | BENZALKONIUM CHLORIDE | F5UM2KM3W7 | SOLUTION / AURICULAR (OTIC) | 0.01 %w/v | ||
| BENZALKONIUM CHLORIDE | BENZALKONIUM CHLORIDE | F5UM2KM3W7 | INJECTION / INTRALESIONAL | 1 mg | ||
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | SOLUTION / OPHTHALMIC | 0.5 %w/v | ||
| HYDROCHLORIC ACID | HYDROCHLORIC ACID | QTT17582CB | INJECTION / INTRACARDIAC | ADJ PH | ||
| HYDROCHLORIC ACID | HYDROCHLORIC ACID | QTT17582CB | INJECTION, SOLUTION / INFILTRATION | ADJ PH | ||
| HYDROCHLORIC ACID | HYDROCHLORIC ACID | QTT17582CB | DROPS / NASAL | 10 ml |
All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N020065-001 | OPCON-A | NAPHAZOLINE HYDROCHLORIDE; PHENIRAMINE MALEATE | 0.02675%;0.315% | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 1994-06-08 |
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N020065-001 | OPCON-A | 0.02675%;0.315% | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 1994-06-08 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | N020065-001 | OPCON-A | 0.02675%;0.315% | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 1994-06-08 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N020065-001 | OPCON-A | 0.02675%;0.315% | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 1994-06-08 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020065-001 | OPCON-A | 0.02675%;0.315% | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 1994-06-08 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N020065-001 | OPCON-A | 0.02675%;0.315% | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 1994-06-08 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020065-001 | OPCON-A | 0.02675%;0.315% | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 1994-06-08 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N020065-001 | OPCON-A | 0.02675%;0.315% | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 1994-06-08 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N020065-001 | OPCON-A | 0.02675%;0.315% | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 1994-06-08 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N020065-001 | OPCON-A | 0.02675%;0.315% | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 1994-06-08 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N020065-001 | OPCON-A | 0.02675%;0.315% | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 1994-06-08 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N020065-001 | OPCON-A | 0.02675%;0.315% | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 1994-06-08 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | N020065-001 | OPCON-A | 0.02675%;0.315% | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 1994-06-08 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N020065-001 | OPCON-A | 0.02675%;0.315% | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 1994-06-08 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N020065-001 | OPCON-A | 0.02675%;0.315% | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 1994-06-08 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N020065-001 | OPCON-A | 0.02675%;0.315% | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 1994-06-08 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | N020065-001 | OPCON-A | 0.02675%;0.315% | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 1994-06-08 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N020065-001 | OPCON-A | 0.02675%;0.315% | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 1994-06-08 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | N020065-001 | OPCON-A | 0.02675%;0.315% | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 1994-06-08 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | N020065-001 | OPCON-A | 0.02675%;0.315% | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 1994-06-08 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | N020065-001 | OPCON-A | 0.02675%;0.315% | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 1994-06-08 | 74a2ff9319b5… | |
| 2022-03-09 01:35 UTC | 2022-03 | N020065-001 | OPCON-A | 0.02675%;0.315% | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 1994-06-08 | bb7c543d1eb4… | |
| 2021-12-28 21:50 UTC | 2021-12 | N020065-001 | OPCON-A | 0.02675%;0.315% | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 1994-06-08 | 782e0a99824c… | |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N020065-001 | OPCON-A | 0.02675%;0.315% | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 1994-06-08 | 87673890dc5c… | |
| 2021-03-12 10:30 UTC | 2021-03 | N020065-001 | OPCON-A | 0.02675%;0.315% | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 1994-06-08 | 5aa47cf7b7d7… | |
| 2020-12-22 03:56 UTC | 2020-12 | N020065-001 | OPCON-A | 0.02675%;0.315% | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 1994-06-08 | 8869cabd3fbd… | |
| 2020-11-12 02:37 UTC | 2020-11 | N020065-001 | OPCON-A | 0.02675%;0.315% | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 1994-06-08 | c0c555d07b60… | |
| 2019-12-14 00:12 UTC | 2019-12 | N020065-001 | OPCON-A | 0.02675%;0.315% | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 1994-06-08 | 3f01610625f2… | |
| 2019-09-15 20:21 UTC | 2019-09 | N020065-001 | OPCON-A | 0.02675%;0.315% | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 1994-06-08 | b00525d2431f… | |
| 2019-07-19 19:46 UTC | 2019-07 | N020065-001 | OPCON-A | 0.02675%;0.315% | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 1994-06-08 | ea99ee380514… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N020065-001 | OPCON-A | 0.02675%;0.315% | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 1994-06-08 | 6a51e52b5d6a… | |
| 2024-02-18 07:12 UTC | 2024-02 | N020065-001 | OPCON-A | 0.02675%;0.315% | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 1994-06-08 | 1c564ffb4f44… | |
| 2023-12-20 04:57 UTC | 2023-12 | N020065-001 | OPCON-A | 0.02675%;0.315% | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 1994-06-08 | ea1830bbd6c7… | |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N020065-001 | OPCON-A | 0.02675%;0.315% | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 1994-06-08 | a72a2bbeb626… | |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N020065-001 | OPCON-A | 0.02675%;0.315% | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 1994-06-08 | 9b2671bbb829… | |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N020065-001 | OPCON-A | 0.02675%;0.315% | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 1994-06-08 | a67488948f0b… | |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N020065-001 | OPCON-A | 0.02675%;0.315% | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 1994-06-08 | 3f0d92c62455… | |
| 2023-05-13 08:27 UTC | 2023-05 | N020065-001 | OPCON-A | 0.02675%;0.315% | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 1994-06-08 | 053a50430f4f… | |
| 2023-01-26 05:58 UTC | 2023-01 | N020065-001 | OPCON-A | 0.02675%;0.315% | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 1994-06-08 | 3bdfa0b2c4d7… | |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | N020065-001 | OPCON-A | 0.02675%;0.315% | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 1994-06-08 | 3a93d1ddd44b… | |
| 2022-10-28 04:53 UTC | 2022-10 | N020065-001 | OPCON-A | 0.02675%;0.315% | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 1994-06-08 | f41ea6bd6efb… |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| b63cc1a6-1d50-48d2-97c5-cbe8f1c74c28 | 10ec7dfa-0fc2-424c-b65b-69ba566340a6 | 2015-01-28 | Warnings | 10ec7dfa-0fc2-424c-b65b-69ba566340a6 |
Adverse event summaries are temporarily unavailable. Other product information remains available.